CellCentric

Bioscience & Disease Healthcare Systems

@CellCentric Website LinkedIn Cambridge, UK

About CellCentric

CellCentric is a biotech company focused on advancing inobrodib in multiple myeloma trials. The company aims to develop innovative therapies for hematological malignancies, particularly targeting relapsed or refractory multiple myeloma.

Business Information

Target Customers

pharmaceutical companies healthcare providers research institutions

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Biopharmaceutical development

Pricing Strategy N/A

Sales Channels partnerships with pharmaceutical companies, clinical trial collaborations

Funding Timeline

Round	Date	Amount	Investors
Series C	May 19, 2025	$120.0M	Pfizer

Founders

No founder information available.

Investors

Pfizer

Corporate Venture Capital

Recent Mentions

BioTech Visionary @BioTechVisions

May 19, 2025

🚨 Pfizer-Backed CellCentric Secures $120M to Advance Inobrodib in Multiple Myeloma Trials 🚨 CellCentric, a Cambridge, U.K.-based biotech company, has raised $120 million in a Series C funding round to propel its lead candidate, inobrodib, into pivotal trials for relapsed or https://t.co/FXPhWeGtTK

View on Twitter

Raising.fi @raisingfi

May 19, 2025

New Raise 🏛️ Company: CellCentric 🔗 Website: https://t.co/aNMUUxDCyR 📊 Amount: $120 Million 🔄 Round: Series C 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

Similar Startups

BioTroy Therapeutics

85% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...

CureGene Pharma

84% match

CureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...

Spark Biomedical

84% match

Spark Biomedical is focused on developing innovative solutions for pain management and addiction tre...

AusperBio

84% match

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.